Augment Health
Developer of an ambulatory bladder pressure monitoring platform for patients with bladder dysfunction. The company combines catheter-based pressure sensing, real-time telemetry and clinician dashboards with preclinical validation and regulatory preparation to enable remote and on-demand urologic monitoring, with a focus on neurogenic bladder.
Industries
Nr. of Employees
small (1-50)
Augment Health
Nashville, Tennessee, United States, North America
Patents
Products
Ambulatory bladder pressure monitor
A catheter-based ambulatory monitoring solution that collects bladder pressure and symptom data over 24–48 hours and transmits data to a clinician dashboard for treatment assessment.
Augment Health Bladder Monitor
A smart bladder monitor enabling ambulatory bladder pressure monitoring for patients with bladder dysfunction throughout the day. It uses a catheter attachment for 24-48 hours to gather bladder health data, which is transmitted to a dashboard for treatment management and assessment.
Ambulatory bladder pressure monitor
A catheter-based ambulatory monitoring solution that collects bladder pressure and symptom data over 24–48 hours and transmits data to a clinician dashboard for treatment assessment.
Augment Health Bladder Monitor
A smart bladder monitor enabling ambulatory bladder pressure monitoring for patients with bladder dysfunction throughout the day. It uses a catheter attachment for 24-48 hours to gather bladder health data, which is transmitted to a dashboard for treatment management and assessment.
Services
Provision of a device attachment and remote monitoring pipeline to collect 24–48 hour bladder pressure data and deliver clinician-facing reports through a dashboard to support treatment assessment and telehealth.
Provision of a device attachment and remote monitoring pipeline to collect 24–48 hour bladder pressure data and deliver clinician-facing reports through a dashboard to support treatment assessment and telehealth.
Expertise Areas
- Ambulatory physiological monitoring
- Urologic device development
- Preclinical validation and animal studies
- Regulatory submission preparation (FDA pre-submission)
Key Technologies
- Catheter-based pressure sensors
- Ambulatory pressure telemetry
- Cloud-based clinician dashboards
- Machine learning for physiological data
News & Updates
Announcement of an investment from Vanderbilt University’s Innovation Investment Committee and summary of recent milestones including a pre-clinical animal study, reimbursement assessment, and FDA pre-submission work.
Completion of a nine-month accelerator program focused on biomedical engineering with mentorship across multiple sprints to advance the active bladder monitoring platform.
Received investment from Vanderbilt University’s Innovation Investment Committee following milestones including preclinical validation and regulatory pre-submission work.
Completed Creative Destruction Lab Vancouver's nine-month Biomedical Engineering accelerator program.
Announcement of an investment from Vanderbilt University’s Innovation Investment Committee and summary of recent milestones including a pre-clinical animal study, reimbursement assessment, and FDA pre-submission work.
Completion of a nine-month accelerator program focused on biomedical engineering with mentorship across multiple sprints to advance the active bladder monitoring platform.
Received investment from Vanderbilt University’s Innovation Investment Committee following milestones including preclinical validation and regulatory pre-submission work.
Completed Creative Destruction Lab Vancouver's nine-month Biomedical Engineering accelerator program.